Barry Douglas has filed 8 insider transactions across 1 company since February 2024.
Most recent transaction: a sale of 2774 shares of Tango Therapeutics, Inc. ($TNGX) on February 04, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2025 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | S | Common Stock | 2774 | $2.99 | 68,570.0000 | 0 | 3.89% | 0.00% |
| Feb. 5, 2025 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | S | Common Stock | 2556 | $3.16 | 66,014.0000 | 0 | 3.73% | 0.00% |
| Feb. 3, 2025 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | A | Common Stock | 27363 | $0.00 | 71,344.0000 | 0 | 62.22% | 0.00% |
| Feb. 3, 2025 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | A | Stock Option (Right to Buy) | 164175 | $0.00 | 164,175.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | S | Common Stock | 1422 | $12.56 | 45,335.0000 | 0 | 3.04% | 0.00% |
| Feb. 7, 2024 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | S | Common Stock | 1354 | $12.62 | 43,981.0000 | 0 | 2.99% | 0.00% |
| Feb. 1, 2024 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | A | Common Stock | 22859 | $0.00 | 22,859.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Tango Therapeutics, Inc. | $TNGX | Barry Douglas | General Counsel | A | Stock Option (Right to Buy) | 137156 | $0.00 | 137,156.0000 | 0 | 9999.99% | 0.00% |